MyAverix Finance
SA · Healthcare
Bristol-Myers Squibb Company (BMYB34)
Drug Manufacturers - General
Bristol-Myers Squibb Company (BMYB34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-29, reported market cap is $630.41B, P/E ratio is 17.04, net margin is 14.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BMYB34
Bristol-Myers Squibb Company (BMYB34) — FAQ
What is Bristol-Myers Squibb Company's market cap?
Bristol-Myers Squibb Company (BMYB34) has a reported market cap of $630.41B (data as of 2026-03-29).
What is BMYB34's P/E ratio?
The price-to-earnings (P/E) ratio for Bristol-Myers Squibb Company (BMYB34) is 17.04 (data as of 2026-03-29).
Does Bristol-Myers Squibb Company pay a dividend?
Dividend yield is not available in the current snapshot for Bristol-Myers Squibb Company (BMYB34). Check the MyAverix Finance app for the latest dividend data.
What sector is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company (BMYB34) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is BMYB34 listed on?
BMYB34 is listed on SA.
What is Bristol-Myers Squibb Company's net margin?
Bristol-Myers Squibb Company (BMYB34) reports a net margin of 14.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.